Flumazenil for hepatic encephalopathy
Flumazenil for hepatic encephalopathy is a topic covered in the Evidence-Based Medicine Guidelines.
To view the entire topic, please sign in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
Citation
"Flumazenil for Hepatic Encephalopathy." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/454321/all/Flumazenil_for_hepatic_encephalopathy.
Flumazenil for hepatic encephalopathy. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/454321/all/Flumazenil_for_hepatic_encephalopathy. Accessed October 14, 2019.
Flumazenil for hepatic encephalopathy. (2019). In Evidence-Based Medicine Guidelines. Available from https://evidence.unboundmedicine.com/evidence/view/EBMG/454321/all/Flumazenil_for_hepatic_encephalopathy
Flumazenil for Hepatic Encephalopathy [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2019 October 14]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/454321/all/Flumazenil_for_hepatic_encephalopathy.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Flumazenil for hepatic encephalopathy
ID - 454321
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/454321/all/Flumazenil_for_hepatic_encephalopathy
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -